Galmed Pharmaceuticals GLMD
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 3.92 | 14 | -12.85 | -2 | -11.02 | 16 |
| 2025Q4 | 6 | 16 | -27.62 | -5 | -23.96 | 19 |
| 2025Q3 | 11.04 | 19 | -9.55 | -2 | -8.5 | 22 |
| 2025Q2 | 14.72 | 21 | -13.34 | -2 | -11.99 | 23 |
| 2025Q1 | 11.52 | 17 | -6.65 | -1 | -5.94 | 19 |
| 2024Q4 | 25.52 | 16 | -18.46 | -3 | -16.27 | 19 |
| 2024Q3 | 54.88 | 18 | -12.67 | -2 | -11.16 | 21 |
| 2024Q2 | 26.4 | 12 | -9.12 | -1 | -8.03 | 13 |
| 2024Q1 | 33.24 | 13 | -9.57 | -1 | -8.19 | 15 |
| 2023Q4 | 43.68 | 14 | -13.7 | -2 | -11.77 | 17 |
| 2023Q3 | 59.52 | 16 | -11.29 | -1 | -9.53 | 18 |
| 2023Q2 | 287.04 | 11 | -14.13 | -2 | -11.35 | 13 |
| 2023Q1 | 614.16 | 12 | -14.4 | -2 | -11.67 | 15 |
| 2022Q4 | 720 | 13 | -18.09 | -3 | -14.1 | 17 |
| 2022Q3 | 447.98 | 16 | -29.35 | -5 | -24.08 | 21 |
| 2022Q2 | 936 | 21 | -16.57 | -4 | -13.89 | 24 |
| 2022Q1 | 2289.6 | 24 | -22.39 | -6 | -18.39 | 30 |
| 2021Q4 | 2620.8 | 30 | -21.86 | -7 | -18.42 | 37 |
| 2021Q3 | 4017.6 | 38 | -18.66 | -8 | -15.97 | 44 |
| 2021Q2 | 4377.6 | 45 | -17.14 | -8 | -14.9 | 52 |